Testing effectiveness (Phase 2)Active Not RecruitingNCT06478212
What this trial is testing
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
Who this might be right for
IDH1-mutant GliomaIDH2-mutant Glioma
Institut de Recherches Internationales Servier 51